R Luoni

435 total citations
20 papers, 343 citations indexed

About

R Luoni is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, R Luoni has authored 20 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 9 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in R Luoni's work include Multiple Myeloma Research and Treatments (14 papers), Peptidase Inhibition and Analysis (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). R Luoni is often cited by papers focused on Multiple Myeloma Research and Treatments (14 papers), Peptidase Inhibition and Analysis (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). R Luoni collaborates with scholars based in Italy, Germany and Japan. R Luoni's co-authors include G. Ucci, Alberto Riccardi, Paolo G. Gobbi, Marco Danova, Daniele Bertoloni, E Ascari, Monica Giordano, Giuliano Mazzini, Silvia Brugnatelli and Margherita Girino and has published in prestigious journals such as Cancer, Stroke and British Journal of Cancer.

In The Last Decade

R Luoni

20 papers receiving 330 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
R Luoni 231 145 137 90 30 20 343
Susan R. Wiersma 260 1.1× 137 0.9× 78 0.6× 75 0.8× 54 1.8× 16 517
D. Urbanitz 458 2.0× 161 1.1× 148 1.1× 83 0.9× 56 1.9× 41 665
LC Lasky 287 1.2× 59 0.4× 153 1.1× 96 1.1× 20 0.7× 12 413
R Cerri 387 1.7× 123 0.8× 153 1.1× 125 1.4× 59 2.0× 32 517
DC Jr Case 365 1.6× 169 1.2× 173 1.3× 115 1.3× 55 1.8× 10 506
M Masi 458 2.0× 218 1.5× 129 0.9× 105 1.2× 42 1.4× 26 597
W Helbig 309 1.3× 60 0.4× 86 0.6× 69 0.8× 50 1.7× 30 423
Colin Story 162 0.7× 74 0.5× 68 0.5× 72 0.8× 17 0.6× 21 371
S Kusumoto 243 1.1× 146 1.0× 80 0.6× 67 0.7× 25 0.8× 18 344
Cheryl Hirsch‐Ginsberg 224 1.0× 86 0.6× 97 0.7× 51 0.6× 63 2.1× 21 371

Countries citing papers authored by R Luoni

Since Specialization
Citations

This map shows the geographic impact of R Luoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Luoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Luoni more than expected).

Fields of papers citing papers by R Luoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Luoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Luoni. The network helps show where R Luoni may publish in the future.

Co-authorship network of co-authors of R Luoni

This figure shows the co-authorship network connecting the top 25 collaborators of R Luoni. A scholar is included among the top collaborators of R Luoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Luoni. R Luoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riccardi, Alberto, G. Ucci, R Luoni, et al.. (1994). Treatment of multiple myeloma according to the extension of the disease: a prospective, randomised study comparing a less with a more aggressive cytostatic policy. British Journal of Cancer. 70(6). 1203–1210. 34 indexed citations
2.
Ucci, G., et al.. (1993). Presenting features of monoclonal gammopathies: an analysis of 684 newly diagnosed cases. Journal of Internal Medicine. 234(2). 165–173. 19 indexed citations
3.
Ucci, G., Mario Petrini, Alberto Riccardi, et al.. (1992). Expression of p170 protein in multiple myeloma: A clinical study. Hematological Oncology. 10(3-4). 213–220. 18 indexed citations
4.
Luoni, R, et al.. (1992). Serum thymidine kinase in monoclonal gammopathies. A prospective study. Cancer. 69(6). 1368–1372. 18 indexed citations
5.
Riccardi, Armando, Rosangela Invernizzi, G. Ucci, et al.. (1991). LA P170 NEL MIELOMA MULITIPLO E NELLE LEUCEMIE ACUTE. Haematologica. 76. 177–180. 2 indexed citations
6.
Giordano, Monica, Alberto Riccardi, Margherita Girino, et al.. (1991). Postremission chemotherapy in adult acute non-lymphoblastic leukaemia including intensive or non-intensive consolidation therapy. European Journal of Cancer and Clinical Oncology. 27(4). 437–441. 6 indexed citations
7.
Girino, Margherita, Alberto Riccardi, R Luoni, G. Ucci, & Anna Cuomo. (1991). Monoclonal Antibody Ki-67 as a Marker of Proliferative Activity in Monoclonal Gammopathies. Acta Haematologica. 85(1). 26–30. 25 indexed citations
8.
Riccardi, Alberto, et al.. (1991). Changing clinical presentation of multiple myeloma. European Journal of Cancer and Clinical Oncology. 27(11). 1401–1405. 88 indexed citations
9.
Riccardi, Alberto, Rosangela Invernizzi, G. Ucci, et al.. (1991). [p170 in multiple myeloma and acute leukemia].. PubMed. 76 Suppl 3. 177–80. 2 indexed citations
10.
Danova, Marco, Alberto Riccardi, G. Ucci, et al.. (1990). Ras oncogene expression and DNA content in plasma cell dyscrasias: a flow cytofluorimetric study. British Journal of Cancer. 62(5). 781–785. 24 indexed citations
11.
Riccardi, Alberto, G. Ucci, R Luoni, et al.. (1990). Bone marrow biopsy in monoclonal gammopathies: correlations between pathological findings and clinical data. The Cooperative Group for Study and Treatment of Multiple Myeloma.. Journal of Clinical Pathology. 43(6). 469–475. 18 indexed citations
12.
Carulli, Giovanni, Mario Petrini, Alessandra Marini, et al.. (1990). P-glycoprotein expression in multiple myeloma.. PubMed. 75(3). 288–90. 9 indexed citations
13.
Ucci, G., Alberto Riccardi, Peter G. Dormer, Marco Danova, & R Luoni. (1988). Early Plasma Cell Recruitment In Multiple Myeloma Following Chemotherapy. Cell Proliferation. 21(6). 405–409. 1 indexed citations
14.
Vicari, A., Alberto Margonato, R Luoni, et al.. (1988). Effects of acute smoking on the hemostatic system in humans. Clinical Cardiology. 11(8). 538–540. 16 indexed citations
15.
Luoni, R, G. Ucci, Alberto Riccardi, et al.. (1988). Serum thymidine kinase in hematologic malignancies.. PubMed. 73(1). 31–5. 5 indexed citations
16.
Ucci, G., Alberto Riccardi, Peter G. Dormer, et al.. (1987). Proliferation kinetics of plasma cells and of normal haemopoietic cells in multiple myeloma. Cell Proliferation. 20(3). 311–318. 4 indexed citations
17.
Vicari, A., et al.. (1987). Platelet function and thrombin activity in patients with recent cerebral transient ischemic attacks.. Stroke. 18(5). 892–895. 7 indexed citations
18.
Danova, Marco, George D. Wilson, Armando Riccardi, et al.. (1987). In vivo administration of bromodeoxyuridine and flow cytometry for cell kinetic studies in human malignancies.. PubMed. 72(2). 115–9. 21 indexed citations
19.
Ucci, G., Alberto Riccardi, R Luoni, et al.. (1987). Serum Thymidine Kinase and Beta-2 Microglobulin in Monoclonal Gammopathies. Tumori Journal. 73(5). 445–449. 11 indexed citations
20.
Montecucco, Carlomaurizio, Alberto Riccardi, G. Ucci, et al.. (1986). Analysis of Human Myeloma Cell Population Kinetics. Acta Haematologica. 75(3). 153–156. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026